Home > Insider Trading > Filing (0001209191-23-038188)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1851194	Ventyx Biosciences Inc.	VTYX	Pharmaceutical Preparations (2834)	832996852

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1923805	J. William Sandborn	C/O Ventyx Biosciences, Inc. 662 Encinitas Blvd, Suite 250 Encinitas CA 92024	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-06-15	2,383	$33.88	32,279	No	4	S	Indirect	By Spouse
Common Stock	Disposition	2023-06-15	1,104	$34.75	31,175	No	4	S	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Spouse
No	4	S	Indirect	By Spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	48,389	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on December 19, 2022.
Represents the weighted average share price of an aggregate total of 2,383 shares sold in the price range of $33.39 to $34.322. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 1,104 shares sold in the price range of $34.445 to $34.9565. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.